Earnings

74% increase in revenues to € 9.3 million for the first nine months of 2018 versus same period in 2017

Net sales amounted to SEK 1,421 million (1,200), an increase of 18%

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

TxCell SA today reports its financial information for the 3rd quarter of 2018.

Epigenomics AG today announced its financial results for the third quarter and the nine months 2018 ending September 30.

Positive preclinical results presented at ESMO

Oxford Immunotec Global PLC today announced that it plans to release third quarter 2018 financial results prior to market open on Friday, November 9, 2018.

According to the resolution of the Annual General Meeting in BioArctic AB (publ) on May 15, 2018 the members of the Nomination Committee for the 2019 Annual General Meeting shall be appointed through a procedure where the three largest shareholders in terms of voting power according to Euroclear’s transcription of the share register as of September 30, 2018 are contacted by the Chairman of the Board and asked to appoint one representative each to the Nomination Committee.

BerGenBio ASA will announce its results for the third quarter 2018 on Tuesday, 13 November 2018.

Acacia Pharma Group plc announces its unaudited results for the nine months to 30 September 2018 to provide an update on current trading and its cash position.